Clinical Trials Directory

Trials / Unknown

UnknownNCT02634359

Evaluation of EarlySense for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment

Protocol for Evaluation of EarlySense - a Contact-less Heart and Respiration Device for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
EarlySense Ltd. · Industry
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The study objective is to collect data to assess the accuracy and reliability of Earlysense fertility cycle monitoring performance vs. acceptable known reference methods such as blood tests and intra-vaginal Ultrasound currently used as validated methods to detect ovulation and pregnancy. In addition the collected data will be used to further enhance and improve the existing algorithms.

Detailed description

The study objective is to assess the accuracy and reliability of Earlysense cycle monitoring to detect ovulation and implantation vs. acceptable known reference methods including blood tests and Ultrasound examination that are currently used as validated methods to detect ovulation and pregnancy. In addition the collected data will be used to further enhance and improve the existing algorithms that detect menses.

Conditions

Interventions

TypeNameDescription
DEVICEEarlySense home devicePassive contact-free monitoring at home measuring HR, RR and movements Arms: IVF Treatments- Frozen Embryo transfer IVF Treatments- Clinical Evaluation No IVF
PROCEDUREVaginal ultrasoundVaginal ultrasound for the purpose of determining follicle size Arms:IVF Treatments- Frozen Embryo transfer IVF Treatments- Clinical Evaluation No IVF
PROCEDUREBlood TestHormonal profile blood tests arms: IVF Treatments- Frozen Embryo transfer IVF Treatments- Clinical Evaluation No IVF

Timeline

Start date
2015-12-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2015-12-18
Last updated
2022-07-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02634359. Inclusion in this directory is not an endorsement.